Pegfilgrastim
NNG04
Phase 1 small_molecule completed
Quick answer
Pegfilgrastim for Breast Cancer is a Phase 1 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed